On December 16, 2013 CDC was informed by Merck that the company planned to implement a voluntary recall of one lot (lot J007354) of Gardasil® [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant], due to the potential for a small number of vials to contain glass particles as a result of breakage during the manufacturing process. Gardasil® is a vaccine recommended for 11-12 year olds in order to prevent human papillomavirus (HPV), a virus that causes cervical cancer. If a person received a vaccine containing glass particles, mild reactions such as swelling at the injection site may occur. The effectiveness of the vaccine is not affected by this problem. The affected vials were distributed between August 20, 2013, and October 9, 2013.
[1] CDC, "Voluntary Recall of One Lot of Gardasil HPV Vaccine" (December 20, 2013).
[1] CDC, "Voluntary Recall of One Lot of Gardasil HPV Vaccine" (December 20, 2013).
RSS Feed
